Neuromyelitis Optica Spectrum Disorder

Researchers aimed to find the occurrence of neuromyelitis optica in patients with systemic lupus erythematosus and primary Sjögren syndrome.

Researchers set out to determine how the retina was impacted by double-antibody seronegative neuromyelitis optica spectrum disorder.

In a multicenter, retrospective study, researchers evaluated time from NMOSD onset to serological diagnosis and factors associated with predicting shorter time to diagnosis.

A team of researchers sought to determine the prevalence of depression and anxiety in patients with NMOSD before their diagnosis of the disease.

A systematic review and meta-analysis examined the clinical differences between adult patients with neuromyelitis optica spectrum disorders and those with multiple sclerosis.

Researchers set out to determine whether renal function could be used as both a predictor of relapse risk for patients with their first onset of aquaporin-4 (AQP4)-immunoglobulin G (IgG)-seropositive...

The US Food and Drug Administration has approved a new treatment for neuromyelitis optica spectrum disorder among adults with the AQP4 antibody.

Researchers investigated the entire spectrum of myelin oligodendrocyte glycoprotein antibody-associated syndromes in children. The frequency, distribution, and treatment response of the syndromes were...

Researchers found that approximately 1 in 7 patients with aquaporin-4 antibody positive (AQP4-IgG+) neuromyelitis optica spectrum disorder (NMOSD) experienced neurologic symptoms before their first attack. ...